Literature DB >> 16846592

S100A8 and S100A9 in inflammation and cancer.

Christoffer Gebhardt1, Julia Németh, Peter Angel, Jochen Hess.   

Abstract

Calprotectin (S100A8/A9), a heterodimer of the two calcium-binding proteins S100A8 and S100A9, was originally discovered as immunogenic protein expressed and secreted by neutrophils. Subsequently, it has emerged as important pro-inflammatory mediator in acute and chronic inflammation. More recently, increased S100A8 and S100A9 levels were also detected in various human cancers, presenting abundant expression in neoplastic tumor cells as well as infiltrating immune cells. Although, many possible functions have been proposed for S100A8/A9, its biological role still remains to be defined. Altogether, its expression and potential cytokine-like function in inflammation and in cancer suggests that S100A8/A9 may play a key role in inflammation-associated cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16846592     DOI: 10.1016/j.bcp.2006.05.017

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  278 in total

1.  TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.

Authors:  Sergey V Novitskiy; Michael W Pickup; Agnieszka E Gorska; Philip Owens; Anna Chytil; Mary Aakre; Huiyun Wu; Yu Shyr; Harold L Moses
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

2.  A CXCL1 paracrine network links cancer chemoresistance and metastasis.

Authors:  Swarnali Acharyya; Thordur Oskarsson; Sakari Vanharanta; Srinivas Malladi; Juliet Kim; Patrick G Morris; Katia Manova-Todorova; Margaret Leversha; Nancy Hogg; Venkatraman E Seshan; Larry Norton; Edi Brogi; Joan Massagué
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

Review 3.  Host-imposed manganese starvation of invading pathogens: two routes to the same destination.

Authors:  Jacqueline R Morey; Christopher A McDevitt; Thomas E Kehl-Fie
Journal:  Biometals       Date:  2015-04-03       Impact factor: 2.949

4.  Potential prognostic biomarkers of pancreatic cancer.

Authors:  Kathryn T Chen; Phillip D Kim; Kelly A Jones; Karthik Devarajan; Bhavinkumar B Patel; John P Hoffman; Hormoz Ehya; Min Huang; James C Watson; Jeffrey L Tokar; Anthony T Yeung
Journal:  Pancreas       Date:  2014-01       Impact factor: 3.327

5.  Protein S100-A8: A potential metastasis-associated protein for breast cancer determined via iTRAQ quantitative proteomic and clinicopathological analysis.

Authors:  Jing-Min Zhong; Jing Li; An-Ding Kang; San-Qian Huang; Wen-Bin Liu; Yun Zhang; Zhi-Hong Liu; Liang Zeng
Journal:  Oncol Lett       Date:  2018-02-06       Impact factor: 2.967

6.  Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics.

Authors:  Carina Bernardo; Maria Cláudia Cunha; Júlio Henrique Santos; José M Correia da Costa; Paul J Brindley; Carlos Lopes; Francisco Amado; Rita Ferreira; Rui Vitorino; Lúcio Lara Santos
Journal:  Tumour Biol       Date:  2016-03-07

7.  Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model.

Authors:  Michał Wiciński; Bartosz Malinowski; Mateusz M Węclewicz; Elżbieta Grześk; Grzegorz Grześk
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

8.  Acinetobacter baumannii response to host-mediated zinc limitation requires the transcriptional regulator Zur.

Authors:  Brittany L Mortensen; Subodh Rathi; Walter J Chazin; Eric P Skaar
Journal:  J Bacteriol       Date:  2014-05-09       Impact factor: 3.490

Review 9.  Nutritional immunity beyond iron: a role for manganese and zinc.

Authors:  Thomas E Kehl-Fie; Eric P Skaar
Journal:  Curr Opin Chem Biol       Date:  2009-12-16       Impact factor: 8.822

10.  S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells.

Authors:  Chae Hwa Kwon; Hyun Jung Moon; Hye Ji Park; Jin Hwa Choi; Do Youn Park
Journal:  Mol Cells       Date:  2013-02-26       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.